Niche's skilled medical writing team engaged with ViiV Healthcare to quickly and efficiently develop high quality documents to support their global outreach activities. This involved:
"We frequently engaged Niche to providing editorial and medical writing support to partner organisations involved in our patient outreach programmes. We also engaged Niche to provide strategic in put on regulatory and medical affairs projects."
Niche and ViiV have had a longstanding collaboration, continuing from support provided to GSK's award winning Positive Action patient advocacy programme. Niche was invited to provide editorial and medical writing services to ViiV’s partner organisations involved in patient outreach programmes. In addition, ViiV also relied on Niche’s strategic input on various regulatory and medical affairs projects.
From very early on, ViiV’s specialist clinical ambitions were well served by Niche’s deep clinical expertise and patient-centric approach. The Niche team recognises that patient care should be paramount at every stage of clinical development. This ethos synergised well with ViiV’s patient outreach programmes.
ViiV faced major challenges in providing global access of essential medications to people living with HIV. Thus, ViiV deployed Niche’s research competencies to inform their global medications access and regulatory strategies. The team’s extensive experience in literature searches meant that they could quickly and flexibly provide ViiV with relevant information, appropriately targeted to their regulatory requirements.
Cleothena Enterprises Pty Ltd. is a forward-thinking biotechnology company focused on advancing innovative therapeutic.
read moreAstex employs its proprietary Pyramidâ„¢ platform to develop innovative therapies targeting challenging or.
read moreThe FRAILOMIC initiative was an international research project aimed at improving the understanding, diagnosis, and.
read moreRecardio is a life science company that focuses on drug-based regenerative therapeutic modalities for treatments of.
read moreAdaptimmune specialises in developing novel therapies for the treatment of resistant tumour types.
read moreThe British Society for Haematology (BSH), the UK’s largest haematology organisation, promotes excellence within the.
read moreNabriva Therapeutics was incorporated as a spin-off from Sandoz GmbH Antibiotics Research Institute (ABRI) in Vienna..
read moreSynairgen is a UK-based biopharmaceutical company focused on developing innovative treatments for respiratory diseases,.
read moreAssign’s business model relied on bespoke service providers like Niche to deliver essential aspects of their business.
read moreBioKinetic Europe was a fully integrated clinical research organisation with its own purpose-designed clinical.
read moreScandinavian Development Services Life Science was a leading consultancy in the Nordics with regards to regulatory.
read moreGet our latest news and publications
Sign up to our news letterSocial
Contact us
Address
Niche Science & Technology
Unit 26 Falstaff House
Bardolph Road
Richmond TW9 2LH
United Kingdom
